Dow Up0.59% Nasdaq Up0.75%

Auxilium Pharmaceuticals Inc. (AUXL)

-NasdaqGS
21.52 0.34(1.56%) Sep 16, 4:00PM EDT
|After Hours : 29.52 Up 8.00 (37.17%) Sep 16, 7:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 83,018   88,519   125,884   108,140  
Cost of Revenue30,094  18,094  36,157  33,553  
Gross Profit 52,924   70,425   89,727   74,587  
Operating Expenses
Research Development11,303  10,994  12,911  11,816  
Selling General and Administrative48,807  85,733  72,644  67,480  
Non Recurring -   -   -   -  
Others19,970  19,761  19,008  15,085  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (27,156) (46,063) (14,836) (19,794)
Income from Continuing Operations
Total Other Income/Expenses Net56  (56)110  105  
Earnings Before Interest And Taxes(27,100)(46,119)(14,726)(19,689)
Interest Expense9,513  9,520  9,605  8,912  
Income Before Tax(36,613)(55,639)(24,331)(28,601)
Income Tax Expense(118)338  13,772  (14,149)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(36,495)(55,977)(38,103)(14,452)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (36,495) (55,977) (38,103) (14,452)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (36,495) (55,977) (38,103) (14,452)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.